Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Galecto, Inc. | 37,313 | reported | 23 Mar 2026 | tx 3+166,313−129 |
| CRISPR Therapeutics AG | 10,544 | reported | 21 Mar 2025 | tx 19+116,733−21,035 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Mar 2026 | GRANT_AWARD | Galecto, Inc. | 37,313 | 0.00 USD | deriv |
| 09 Feb 2026 | EXERCISE | Galecto, Inc. | 129,000 | 0.00 USD | |
| 09 Feb 2026 | EXERCISE | Galecto, Inc. | 129 | 0.00 USD | deriv |
| 20 Mar 2025 | EXERCISE | CRISPR Therapeutics AG | 3,750 | — | |
| 21 Mar 2025 | SALE | CRISPR Therapeutics AG | 1,714 | 41.23 USD | |
| 20 Mar 2025 | EXERCISE | CRISPR Therapeutics AG | 3,750 | — | deriv |
| 14 Mar 2025 | GRANT_AWARD | CRISPR Therapeutics AG | 27,500 | 0.00 USD | deriv |
| 14 Mar 2025 | GRANT_AWARD | CRISPR Therapeutics AG | 36,666 | 0.00 USD | deriv |
| 10 Mar 2025 | EXERCISE | CRISPR Therapeutics AG | 2,399 | — | |
| 11 Mar 2025 | SALE | CRISPR Therapeutics AG | 1,198 | 42.42 USD | |
| 12 Mar 2025 | SALE | CRISPR Therapeutics AG | 190 | 43.32 USD | |
| 11 Mar 2025 | EXERCISE | CRISPR Therapeutics AG | 435 | — | |
| 11 Mar 2025 | EXERCISE | CRISPR Therapeutics AG | 435 | — | deriv |
| 10 Mar 2025 | EXERCISE | CRISPR Therapeutics AG | 2,399 | — | deriv |
| 18 Feb 2025 | EXERCISE | CRISPR Therapeutics AG | 650 | — | |
| 19 Feb 2025 | SALE | CRISPR Therapeutics AG | 333 | 52.80 USD | |
| 18 Feb 2025 | EXERCISE | CRISPR Therapeutics AG | 650 | — | deriv |
| 16 Oct 2024 | GRANT_AWARD | CRISPR Therapeutics AG | 18,333 | 0.00 USD | deriv |
| 21 Jun 2024 | SALE | CRISPR Therapeutics AG | 3,366 | 56.09 USD | |
| 20 Jun 2024 | EXERCISE | CRISPR Therapeutics AG | 7,000 | — | |
| 20 Jun 2024 | EXERCISE | CRISPR Therapeutics AG | 7,000 | — | deriv |
| 23 May 2024 | GRANT_AWARD | CRISPR Therapeutics AG | 20,000 | 0.00 USD | deriv |